OTC · Medical - Pharmaceuticals

H. Lundbeck A/S (HLUBF) Stock

$5.50 +0.00% OTC: HLUBF Healthcare

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders.

Valuation

MetricValue
Price$5.50
Market Cap$5.84B
P/E Ratio11.50
P/B Ratio1.66
P/S Ratio1.35
EPS (TTM)$0.48
52-Week High$6.41
52-Week Low$3.70
Dividend Yield3.27%

Financials & Margins

MetricValue
ROE14.81%
ROA7.07%
ROCE16.17%
Gross Margin78.95%
Operating Margin27.86%
Net Margin14.71%
Debt/Equity0.43
Current Ratio1.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.3B$18.2B$19.9B$22.0B$24.3B
Operating Profit$2.0B$2.9B$3.2B$3.3B$6.3B
Net Profit$1.3B$1.9B$2.3B$3.1B$3.2B
EPS$1.33$1.93$2.31$3.17$3.21
Op Margin12.3%15.6%16.1%14.9%26.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$34.7B$37.5B$37.4B$57.0B$53.9B
Total Liabilities$16.4B$16.7B$15.4B$32.0B$29.0B
Cash$2.3B$3.4B$5.0B$4.7B$3.4B
Borrowings$5.3B$5.6B$4.2B$16.7B$11.7B

Latest News

H. Lundbeck AS (HLUBF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... GuruFocus.com · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.3B$3.5B$4.1B$3.3B$4.9B
Investing Cash Flow$-1.4B$-2.7B$-999.0M$-15.9B$-1.2B
Financing Cash Flow$-116.0M$-138.0M$-132.0M$-135.0M$488.0M
Net Cash Flow$-1.6B$1.3B$1.5B$-346.0M$-680.0M
Free Cash Flow$1.7B$2.7B$3.6B$2.8B$4.3B

Valuation & Return Ratios

MetricValue
PEG Ratio0.95
EV / EBITDA5.51
FCF Yield12.68%
Quick Ratio0.90
Interest Coverage11.75
Return 1Y95.23%
Return 3Y129.39%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About H. Lundbeck A/S

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

H. Lundbeck A/S is headquartered in DK.

H. Lundbeck A/S (HLUBF) stock trades at $5.50 with a market capitalization of $5.84B. The stock is valued at a price-to-earnings (P/E) ratio of 11.50, price-to-book of 1.66, price-to-sales of 1.35. Over the past 52 weeks the stock has ranged between $3.70 and $6.41, and currently trades 14.2% below its 52-week high. It pays a dividend yielding 3.27%.

On profitability, H. Lundbeck A/S generates a return on equity (ROE) of 14.81%, above the typical market average, return on capital employed of 16.17%, an operating margin of 27.86%, a net profit margin of 14.71%.

Official website: www.lundbeck.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides